Evidence map›Paper›PMID 40585148›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Wearable-Echo-FM: An ECG-echo foundation model for single lead electrocardiography.

Elizabeth Knight, Evangelos K Oikonomou, Arya Aminorroaya, Aline F Pedroso, Rohan Khera

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Elizabeth KnightSection of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID 0009-0007-5833-0124
Evangelos K OikonomouSection of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0003-4362-0720
Arya AminorroayaSection of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0003-3197-2657
Aline F PedrosoSection of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Rohan KheraSection of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0001-9467-6199

Funding

Deep learning enhanced detection and personalized monitoring of aortic stenosis - The DETECT-AS StudyR01AG089981 · NIA · YALE UNIVERSITY · PI Rohan Khera · 2024 to 2026
$2.4M
Translating Personalized Inference from Randomized Clinical Trials to Real-World Cardiovascular CareR01HL167858 · NHLBI · YALE UNIVERSITY · PI Rohan Khera · 2024 to 2026
$2.3M
Evaluating and Improving Utilization of Evidence-Based Medical Therapy in Patients with Heart Failure using Automated Tools in the Electronic Health RecordK23HL153775 · NHLBI · YALE UNIVERSITY · PI KHERA, ROHAN · 2021 to 2025
$918k
NHLBI NIH HHS K23 HL153775NHLBI NIH HHS R01 HL167858NIA NIH HHS R01 AG089981
6 · The paper itself

Abstract

Artificial intelligence (AI) models can now detect patterns of structural heart diseases (SHDs) from electrocardiograms (ECGs), though scaling them requires the broader use of single-lead ECGs that are now ubiquitous in wearable and portable devices. However, model development for these devices is limited by a lack of diagnostic labels for SHDs for wearable ECGs. Here, we present Wearable-Echo-FM, a foundation model that encodes single-lead ECGs with information from echocardiographic text reports. Using 274,057 single-lead ECG-echo pairs from 77,378 adults (2015-2019), we contrastively pre-trained convolutional neural network (CNN) and RoBERTa encoders. The ECG encoder was fine-tuned on a distinct progressively larger ECG set (250 to 250,260 ECGs) to detect different cardiac disorders (i) left-ventricular systolic dysfunction (LVSD), (ii) diastolic dysfunction, and (iii) a composite SHD. This was compared with a randomly initialized CNN, with both approaches evaluated in an independent held-out test set. With the full training set, Wearable-Echo-FM matched the baseline CNN (AUROC 0.894 vs 0.884 for LVSD; 0.849 vs 0.843 diastolic dysfunction; 0.887 vs 0.869 composite). With only 0.5% (~1000 ECGs) of data, it markedly outperformed baseline (0.855 vs 0.548; 0.819 vs 0.582; 0.863 vs 0.496, respectively). Contrastive pre-training of single-lead ECGs on echocardiographic text reduces label requirements for SHD screening on wearable and portable devices.

Identifiers

PMID40585148
PMCPMC12204444

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.